Eleni Markoutsa
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 12
- Nanoparticle-Based Drug Delivery 7
- Supramolecular Self-Assembly in Materials 5
-
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 3
- Co-authors
- Sophia G. Antimisiaris (13 shared papers)Spyridon Mourtas (7 shared papers)Peisheng Xu (5 shared papers)Adina N. Lazar (2 shared papers)Charles Duyckaerts (1 shared paper)Κωνσταντίνα Παπαδιά (6 shared papers)Huacheng He (2 shared papers)Georgios Pampalakis (2 shared papers)
- Journals
- Nanomedicine Nanotechnology Biology and Medicine (3 papers)Acta Biomaterialia (2 papers)European Journal of Medicinal Chemistry (2 papers)European Journal of Pharmaceutical Sciences (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)
- Partner nations
- GreeceUnited StatesItaly
In The Last Decade
Eleni Markoutsa
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 98
- Biomaterials 343
- Pharmaceutical Science 126
- Molecular Medicine 81
- Neurology 81
- Physiology 240
Countries citing papers authored by Eleni Markoutsa
This map shows the geographic impact of Eleni Markoutsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni Markoutsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni Markoutsa more than expected).
Fields of papers citing papers by Eleni Markoutsa
This network shows the impact of papers produced by Eleni Markoutsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni Markoutsa. The network helps show where Eleni Markoutsa may publish in the future.
Co-authors
The 25 scholars most cited alongside Eleni Markoutsa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 197 | |
| 2 | 2010 | 105 | |
| 3 | 2007 | 78 | |
| 4 | 2011 | 66 | |
| 5 | 2018 | 62 | |
| 6 | 2017 | 55 | |
| 7 | 2013 | 55 | |
| 8 | 2017 | 55 | |
| 9 | 2016 | 54 | |
| 10 | 2011 | 52 | |
| 11 | 2012 | 46 | |
| 12 | 2017 | 45 | |
| 13 | 2021 | 35 | |
| 14 | 2017 | 33 | |
| 15 | 2017 | 31 | |
| 16 | 2020 | 22 | |
| 17 | 2014 | 22 | |
| 18 | 2016 | 17 | |
| 19 | 2018 | 11 | |
| 20 | 2013 | 9 |
About Eleni Markoutsa
Eleni Markoutsa is a scholar working on Biomaterials, Molecular Biology, Physiology, Biomedical Engineering and Materials Chemistry, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Alzheimer's disease research and treatments (5 papers), Supramolecular Self-Assembly in Materials (5 papers), RNA Interference and Gene Delivery (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Nanocluster Synthesis and Applications (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Biomaterials (343 citations), Pharmaceutical Science (126 citations), Molecular Medicine (81 citations), Neurology (81 citations) and Physiology (240 citations). Eleni Markoutsa has collaborated with scholars based in Greece, United States and Italy. Frequent co-authors include Sophia G. Antimisiaris, Spyridon Mourtas, Peisheng Xu, Adina N. Lazar, Charles Duyckaerts, Κωνσταντίνα Παπαδιά, Huacheng He, Georgios Pampalakis, Sotiris Tsakas and Vassilis J. Marmaras. Their work appears in journals such as Nanomedicine Nanotechnology Biology and Medicine, Acta Biomaterialia, European Journal of Medicinal Chemistry, European Journal of Pharmaceutical Sciences and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.